226 related articles for article (PubMed ID: 17952817)
21. [Side effects of antiretroviral treatment for transmission prophylaxis in preterm and near-term infants].
Schlösser R; Linde R; Dunsch D; Reitter A; Haberl A; Bauer K
Z Geburtshilfe Neonatol; 2007 Dec; 211(6):230-5. PubMed ID: 18176903
[TBL] [Abstract][Full Text] [Related]
22. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
[TBL] [Abstract][Full Text] [Related]
23. Perinatal outcome in preterm premature rupture of membranes at < or = 32 weeks with retained cerclage.
Kominiarek MA; Kemp A
J Reprod Med; 2006 Jul; 51(7):533-8. PubMed ID: 16913543
[TBL] [Abstract][Full Text] [Related]
24. Preterm premature rupture of membranes: experience with latent periods in excess of seven days.
Philipson EH; Hoffman DS; Hansen GO; Ingardia CJ
Am J Perinatol; 1994 Nov; 11(6):416-9. PubMed ID: 7857433
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of vertical transmission of HIV in Denmark].
Rasmussen MB; Rasmussen JB; Nielsen VR; Herlin T; Fisker N; Hornstrup MK; Vinter H; Olofsson M; Weis NM
Ugeskr Laeger; 2008 Aug; 170(34):2567-70. PubMed ID: 18761841
[TBL] [Abstract][Full Text] [Related]
26. [Management of HIV-positive pregnancies -- results from a retrospective study].
Ahr A; Faul-Burbes C; Haardt N; Linde R; Haberl A; Bremerich D; Kissler S; Schloesser R; Kaufmann M
Zentralbl Gynakol; 2005 Aug; 127(4):242-7. PubMed ID: 16037906
[TBL] [Abstract][Full Text] [Related]
27. Expectant management of midtrimester premature rupture of membranes: a plea for limits.
Grisaru-Granovsky S; Eitan R; Kaplan M; Samueloff A
J Perinatol; 2003; 23(3):235-9. PubMed ID: 12732862
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.
Reitter A; Stücker AU; Linde R; Königs C; Knecht G; Herrmann E; Schlößer R; Louwen F; Haberl A
HIV Med; 2014 Oct; 15(9):525-36. PubMed ID: 24602285
[TBL] [Abstract][Full Text] [Related]
29. The role of continuous fetal monitoring in the management of preterm premature rupture of membranes.
Davis JM; Krew MA; Gill P; Nelson KM; Hopkins MP
J Matern Fetal Neonatal Med; 2008 May; 21(5):301-4. PubMed ID: 18446655
[TBL] [Abstract][Full Text] [Related]
30. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
31. Outcome of pregnancies with preterm prelabor rupture of membranes before 27 weeks' gestation: a retrospective cohort study.
van der Heyden JL; van der Ham DP; van Kuijk S; Notten KJ; Janssen T; Nijhuis JG; Willekes C; Porath M; van der Post JA; Halbertsma F; Mol BW; Pajkrt E
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):125-30. PubMed ID: 23845169
[TBL] [Abstract][Full Text] [Related]
32. Antibiotics: treatment of preterm labor.
Reimer T; Ulfig N; Friese K
J Perinat Med; 1999; 27(1):35-40. PubMed ID: 10343932
[TBL] [Abstract][Full Text] [Related]
33. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
34. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
35. Use of ampicillin and corticosteroids in premature rupture of membranes: a randomized study.
Morales WJ; Angel JL; O'Brien WF; Knuppel RA
Obstet Gynecol; 1989 May; 73(5 Pt 1):721-6. PubMed ID: 2704497
[TBL] [Abstract][Full Text] [Related]
36. Post-operative complications after caesarean section in HIV-infected women.
Ferrero S; Bentivoglio G
Arch Gynecol Obstet; 2003 Oct; 268(4):268-73. PubMed ID: 14504867
[TBL] [Abstract][Full Text] [Related]
37. Appropriate antenatal corticosteroid use in women at risk for preterm birth before 34 weeks of gestation.
Mahony R; McKeating A; Murphy T; McAuliffe F; O'Herlihy C; Foley M
BJOG; 2010 Jul; 117(8):963-7. PubMed ID: 20465556
[TBL] [Abstract][Full Text] [Related]
38. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
[TBL] [Abstract][Full Text] [Related]
39. Rapid human immunodeficiency virus testing on labor and delivery.
Rahangdale L; Cohan D
Obstet Gynecol; 2008 Jul; 112(1):159-63. PubMed ID: 18591321
[No Abstract] [Full Text] [Related]
40. [The risk of vertical HCV transmission in children born to HIV infected mothers].
Dobosz S
Przegl Epidemiol; 2007; 61(2):349-56. PubMed ID: 17956053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
